PHBV/Sol-gel Bioglass多孔材料在模拟生理溶液中的化学反应研究

3-羟基丁酸-co-3-羟基戊酸共聚物(PHBV)/生物活性玻璃(SGBG)是一种用于骨和软骨组织工程支架的新型多孔复合材料,本文探讨了PHBV/SGBG在模拟生理溶液中的一系列化学反应,以及多孔材料在模拟生理溶液中浸泡后的成分和结构变化.研究结果表明,在SBF溶液中浸泡后,SGBG与SBF溶液的离子交换反应和PHBV的降解反应使SBF溶液的离子浓度发生变化,并在PHBV/SGBG表面形成了结晶态类骨碳酸羟基磷灰石.     

PHBV纳米纤维的静电纺丝及在生物医用领域的研究进展

聚(3-羟基丁酸酯-3-羟基戊酸酯)(PHBV)纳米纤维具有高比表面积、高孔隙率、生物相容性、生物降解性等优点,可用作生物医用材料。本文综述了基于静电纺丝法制备的PHBV纳米纤维及其在生物医用领域的研究进展,讨论了PHBV纺丝溶液的溶剂、浓度、外加盐类以及聚合物等对PHBV纳米纤维形貌、结构及性能的影响规律,结合目前PHBV纳米纤维在组织工程和药物运输载体的研究现状,重点概述了其亲水改性、力学性能改善、功能化改性的研究进展。最后,对静电纺丝法制备PHBV纳米纤维存在的一些问题进行分析,并对其未来发展趋势和前景进行展望。     

PHBV/HA骨修复材料的研究

利用硝酸钙与磷酸钠的水溶液制备羟基磷灰石(HA)，同时在HA生成过程中与聚羟基丁酸一戊酸酯(PHBV)复合，探索了HA增强PHBV使之适于作为骨修复材料的一种新途径。结果表明，HA的均匀分散增进了复合材料中两相问的相互结合，能明显地提高复合材料的力学性能。     

衰减全反射-红外成像研究聚乳酸/生物活性玻璃复合材料的体外矿化过程

采用衰减全反射-红外成像技术(ATR-FTIR mapping)对多孔聚乳酸/生物活性玻璃(PLLA/BG)复合材料在PBS缓冲液中的矿化过程进行了研究。光谱分辨率为8 cm!1,累加扫描8次,基于A1044/A1755的吸光度比值生成红外图像。成像结果表明,随着矿化进行,材料表面产生的羟基磷灰石(HA)也逐渐增多,当矿化进行到84 d后,材料表面大部分已被HA覆盖。但随着矿化时间的继续延长,矿化不均匀性也逐渐加剧。矿化曲线显示矿化过程存在4个阶段:矿化初期(前21 d),产生的HA很少;矿化增长期(21~70 d),BG逐渐转变为HA;快速增长期(70~91 d),矿化加速,并在91 d时达到最大;矿化后期(91 d后),曲线先显示平稳然后又从105 d起出现下降。研究表明,红外成像技术有望成为骨组织工程支架材料的重要研究工具。     

羟基磷灰石/胶原矿化机理的研究进展

仿生合成的羟基磷灰石(HAp)/胶原复合材料的结构和成分与天然骨相似,具有很好的生物相容性、生物活性和生物可降解性,有望成为新一代的骨替代材料。羟基磷灰石/胶原矿化过程其实质是晶体在自组装的胶原纤维上形成的过程,但这一过程在体内是如何进行的至今仍然不清楚。对胶原矿化机理的研究能为制备具有更优越结构和功能的新型骨替代材料提供理论参考。本文概述了羟基磷灰石/胶原矿化机理的研究进展。     

非石油基高分子材料聚羟基脂肪酸酯PHA的改性研究进展

综述了近年来国内外在新型生物可降解材料聚羟基脂肪酸酯(Polyhydroxyalkanoates,PHA)家族主要代表:聚羟基丁酸酯(PHB)、聚3-羟基丁酸酯-co-3-羟基戊酸酯的共聚物(PHBV),聚3-羟基丁酸酯-co-4-羟基丁酸酯的共聚物(P3/4HB)和聚3-羟基丁酸酯-co-3-羟基己酸酯的共聚物(PHBHHx)的生物、化学和物理三种改性和加工方面的研究进展。通过生物方法可以使PHA材料的化学结构、组成、机械力学性能和成型加工性能更具有多样性和可调性;通过化学途径可以使PHA材料的功能性进一步突出和增强,例如可以使PHA为基础的材料具有优异的生物医学性能,同时也具有好的加工性能;利用物理共混和反应性挤出使PHA材料的所有性能缺陷得到进一步修补,使其更具有实用价值。近十年来,通过以上这些改性手段的结合,PHA力学性能不均衡和成型加工的难题得到了解决,使PHA生物聚酯这类新型非石油基高分子材料得到了飞速发展,其综合性能甚至价格具备了代替部分石油基高分子材料的可能,PHA生物聚酯的规模化工业制造和应用的时代已经来临。     

异相成核和拉伸诱导对生物基PHBV复合纤维结晶结构与力学性能的影响

采用熔融纺丝法制备了聚(3-羟基丁酸酯-co-3-羟基戊酸酯)(PHBV)/二硫化钨(WS_2)复合纤维.利用示差扫描量热仪(DSC)、热台偏光显微镜、二维广角射线衍射仪(2D-WXRD)、纤维强力仪研究了WS_2异相成核作用和牵伸诱导作用对纤维的结晶结构和力学性能的影响.研究表明,WS_2显著提高了PHBV的结晶温度,当使用2 wt%WS_2时,复合材料的结晶温度提高到115~130oC,比纯PHBV(99~105oC)提高了约25oC.WS_2不仅没有影响PHBV球晶的径向生长速率,且明显提高了PHBV/WS_2复合材料的晶核密度,熔体成核活性Φ由1.0降低为0.49.随着牵伸倍率和WS_2用量的增加,纤维的拉伸强度呈现出先增加后减小的趋势.当添加1 wt%WS_2并采用单向牵伸3.8倍时,纤维中的晶体取向产生了β晶结构,使复合纤维的拉伸强度由纯PHBV的37 MPa提高至155 MPa,断裂伸长率由2.4%增加至45%.     

β-羟基丁酸与β-羟基戊酸酯共聚物/有机化蒙脱土纳米复合材料热性能、结晶性能与生物降解性能的研究

采用溶液插层法制备了β-羟基丁酸与β-羟基戊酸酯共聚物(PHBV)有机化蒙脱土(OMMT)的纳米复合材料．用示差热分析(DSC)，热重分析(TG)和偏光显微镜(POM)研究了材料的热性能和结晶行为．通过土壤悬浊降解培养法研究了材料的生物降解性．结果表明，材料的熔点和熔融焓随OMMT含量的增加而降低．OMMT在纳米复合材料中的均匀分散，使材料形成了小尺寸的结晶，并有效降低了PHBV的结晶度，提高了结晶速率．在土壤悬浊液中该材料的生物降解性随着OMMT含量的增加而降低．     

聚乳酸接枝改性纳米生物玻璃/PLGA复合材料的制备、表面性质及生物活性

以丙交酯开环聚合原位接枝改性的纳米生物玻璃(PLLA-g-BG)与聚丙交酯-乙交酯(PLGA)复合材料为研究对象, 采用TGA, ESEM和EDX分析其接枝率, 粒子分散性和表面元素分布, 通过将兔成骨细胞种植于材料膜表面进行体外培养, 采用荧光染色法、NIH Image J图像分析软件、MTT法和流式细胞术等手段检测细胞在材料表面的平均黏附数量、扩展面积比、增殖能力和细胞周期的变化, 综合评价新型改性纳米复合材料的生物相容性和生物活性. 结果表明, 聚乳酸表面接枝改性可明显改善纳米生物玻璃粒子的团聚; PLGA中掺入一定比例的改性PLLA-g-BG可明显促进兔成骨细胞的黏附、扩展与增殖; 改性纳米生物玻璃的应用可提高生物可降解聚酯材料的生物相容性和生物活性.     

PHBV-GMA与PHBV-GMA/PPC共混物中接枝物的热性能与形态结构

以甲基丙烯酸缩水甘油酯(GMA)单体对聚(3-羟基丁酸酯-3-羟基戊酸酯)(PHBV)接枝改性,得到的产物PHBV-GMA与封端后的聚碳酸亚丙酯(PPC)反应性共混。索氏抽提器提取PHBV-GMA和PHBV-GMA/PPC共混物,分别得到两种接枝产物PHBV-g-GMA和PHBV-g-PPC,用差示扫描量热法(DSC)、偏光显微镜(POM)以及原子力显微镜(AFM)研究其热性能和形态结构。结果发现,GMA接枝后,对PHBV结晶有成核效应。PPC接枝PHBV后,接枝物PHBV-g-PPC结晶度降低,球晶尺寸减小,PHBV和PPC两种大分子间的相分离程度降低,相容性明显提高。     

In vitro bioactivity of Polyurethane/85S Bioglass composite scaffolds

In the present work Polyurethane (PU)/Bioglass (BG) composite materials were synthesized with different content of BG (10 and 20 mol.%) as filler. The 85S Bioglass was synthesized via polystep sol-gel method. The chemical composition of BG is 85SiO₂-10CaO-5P₂O₅ (wt.%). The synthesis of PU was carried out by a two-step polyaddition reaction. The 85S BG was added in situ during the polymerization reaction. In vitro bioactivity of the prepared composites was examined in the presence of 1.5 SBF for 7 days in static conditions. The structure of synthesized PU/BG composites before and after in vitro test was determined by XRD, FTIR and SEM. XRD of the samples before in vitro test proved that the phase of γCa₂P₂O₇ in the PU/20BG is visible. FTIR revealed the presence of urethane bond between OH-(from BG) and NCO groups (from PU). Based on FTIR results after in vitro test in 1.5 SBF solutions, A/B-carbonate containing hydroxyapatite (CO₃HA) was formed. XRD proved that HA was formed on the surface of the samples, but Ca₂P₂O₇ does not undergo any changes in the 1.5 SBF solution. SEM depicted the nano-HA agglomerated in spherical particles after immersion in 1.5 SBF for 7 days.     

羟基磷灰石／胶原／植物多酚复合材料的研究

以原花色素、茶多酚等植物多酚为交联剂,采用低温原位合成法制备羟基磷灰石/胶原/植物多酚(HA/COL/PP)复合材料。对材料的形貌、热稳定性、溶胀性质进行了表征。结果表明,植物多酚的加入使复合材料中各成分结合更紧密,增加了复合材料的热稳定性,降低了复合材料的溶胀度。比较研究表明,添加原花色素对上述性能的改善更有效。为了考察加入植物多酚后复合材料的生物活性,分别对羟基磷灰石/胶原/原花色素(HA/COL/PA)、羟基磷灰石/胶原/茶多酚(HA/COL/TP)复合材料进行了体外矿化能力研究,观察到两种材料的表面都形成了新的矿化沉积层,说明加入了植物多酚不影响复合材料的体外矿化能力。因而,羟基磷灰石/胶原/植物多酚复合材料是一种有潜力的骨替代材料。     

造孔剂对电泳沉积制备多孔HA涂层及其生物活性的影响

采用水热法制得的羟基磷灰石(HA)纳米粉体,分别与造孔剂葡萄糖(Glu)、壳聚糖(CS)、炭粉(C)3种微粒(＜38.5 μm)配置成质量比1∶1的悬浮液,电泳沉积 烧结制备钛基多孔HA涂层,并对制得的3种多孔HA涂层在模拟体液浸泡前后的表面形貌、化学组成及物相变化进行表征。 结果表明,经700 ℃烧结处理后制得的3种多孔HA涂层在1.5倍人体模拟体液中浸泡5 d后,多孔HA涂层表面均被层状生长的碳磷灰石颗粒完全覆盖,颗粒直径在5~25 μm,说明这些多孔HA涂层均具有良好的生物活性。 其中以CS为造孔剂制得的多孔HA涂层结合强度最高,达19.5 MPa,有望开发成为新型的人骨植入生物陶瓷材料。     

羟基磷灰石/氧化铁复合涂层的制备及其诱导骨生长的生物活性

用电泳沉积法制得羟基磷灰石/壳聚糖/氧化铁(HA/CS/Fe2O3)复合涂层,经700 ℃烧结处理得到HA/Fe2O3复合涂层。 通过SEM、EDS、XRD、FT-IR、电化学和万能材料试验机等对复合涂层的表面形貌、物相组成、抗腐蚀性和结合强度进行了表征和测试,最后采用1.5SBF浸泡法对复合涂层的生物活性进行了评价。 结果表明,当悬浮液中的HA、CS与Fe2O3质量比为100∶100∶1时,所制得的HA/Fe2O3复合涂层表面粗糙,抗腐蚀性强,具有良好的诱导骨生长生物活性,基体与复合涂层结合强度可达27.5 MPa。     

桑蚕丝素蛋白初始结构对其矿化作用的影响

以碱金属离子诱导桑蚕丝素蛋白溶液发生构象转变, 研究了蛋白质初始结构对其矿化作用的影响. FT-IR, XRD和SEM等测试结果显示, 未经任何处理的桑蚕丝素蛋白溶液矿化后形成片状复合物, 其无机相以二水磷酸氢钙(DCPD)为主; 而经过K^＋和Na^＋金属离子处理后, 桑蚕丝素溶液的结构由无规线团/螺旋构象向β-折叠发生转变, 矿化后成纤维状, 并相互结合呈现纳米级的三维多孔结构, 其无机相以热力学稳定的羟基磷灰石(HA)为主. 可以认为, 丝素蛋白结构转化为较伸展的β-折叠后, 使得更多的亲水基团暴露在外面, 在丝素蛋白分子不断凝聚成纤过程中, HA结晶快速生长并附着在这些微纤上, 最终形成纤维状的丝素蛋白/HA复合物. 该结果为阐明蛋白质的生物矿化过程及其调控机理提供了理论依据, 同时可以从矿化复合物的形成来反映这些微量元素可能对骨组织形成的影响, 为临床骨组织的修复提供一定的参考.     

Bioactivity of a Bio-composite Fabricated from CoCrMo/Bioactive Glass by Powder Metallurgy Method for Biomedical Application

In present times, researchers are attracted towards studies on biocomposite as a potential biodegradable bone implant materials. Bioactivity of the composite in a simulated body fluid (SBF) was investigated. A porous Co-Cr-Mo based composite material with bio-glass 45S5 was produce by using powder metallurgy method (PM) technology. Prepared composite powders were cold pressed and sintered at 1000 °C for 2 h. X-ray diffraction (XRD), scanning electron microscopy were used for phase analysis and also for evaluation of particle distribution of composites. Bioactivity behaviour of the prepared nanocomposites was evaluated in simulated body fluid (SBF) for 1 up to 18 days. The results showed that the apatite layer were formed on the surface of sample with addition of bioactive glass. It was concluded that bioinert Co-Cr-Mo alloy could be successfully converted into bioactive composite by adding 6 wt% of BG particles.     

Control of surface topography in biomimetic calcium phosphate coatings

The behavior of cells responsible for bone formation, osseointegration, and bone bonding in vivo are governed by both the surface chemistry and topography of scaffold matrices. Bone-like apatite coatings represent a promising method to improve the osteoconductivity and bonding of synthetic scaffold materials to mineralized tissues for regenerative procedures in orthopedics and dentistry. Polycaprolactone (PCL) films were coated with calcium phosphates (CaP) by incubation in simulated body fluid (SBF). We investigated the effect of SBF ion concentration and soaking time on the surface properties of the resulting apatite coatings. CaP coatings were examined by scanning electron microscopy (SEM), X-ray diffraction (XRD), Fourier transform infrared spectrometry (FTIR), and energy dispersive X-ray spectrometry (EDX). Young's modulus (E(s)) was determined by nanoindentation, and surface roughness was assessed by atomic force microscopy (AFM) and mechanical stylus profilometry. CaP such as carbonate-substituted apatite were deposited onto PCL films. SEM and AFM images of the apatite coatings revealed an increase in topographical complexity and surface roughness with increasing ion concentration of SBF solutions. Young's moduli (E(s)) of various CaP coatings were not significantly different, regardless of the CaP phase or surface roughness. Thus, SBF with high ion concentrations may be used to coat synthetic polymers with CaP layers of different surface topography and roughness to improve the osteoconductivity and bone-bonding ability of the scaffold.     

Adsorption behavior of nicotine on periodic mesoporous organosilicas

In this study, we focused on the adsorption of nicotine from aqueous solution such as water and simulated body fluids (SBFs), where SBF has ion concentrations approximately equal to those of human blood plasma. We prepared periodic mesoporous organosilica (PMO) materials as adsorbents from 4,4-bis(triethoxysilyl)biphenyl (BTES-biphenyl), 1,4-bis(triethoxysilyl)benzene (BTES-benzene) and bis[3-(trimethoxy silyl)propyl]amine (BTMS-amine) as precursors and investigated on their adsorption behavior of nicotine as a guest material under different solvent conditions. For this work, two different kinds of SBF, c-SBF and r-SBF, have been chosen, where c-SBF is a transitional SBF solution, and r-SBF is a modified SBF solution that is closer to human blood plasma. Adsorption of nicotine on PMOs has been characterized by a UV-Vis spectroscopy. The adsorption behavior was strongly dependent on the isoelectric point and hydrophobicity of the PMO as well as the hydrophobicity of nicotine.     

Potential applications of fluorhydroxyapatite as biomaterials in medicine

The present work was undertaken to investigate the bioactivity and cytotoxicity of fluorhydroxyapatite ceramics. The bioactivity was evaluated by in vitro testing in simulated body fluid (SBF), in which ion concentrations are almost identical with inorganic ion concentrations of human blood plasma. Pellets of FA, HA and FHA were immersed in SBF for 48 hours, 1 week and 4 weeks at 36.5°C. Changes of the surface microstructure of the samples were observed by scanning electron microscopy (SEM). 48 hours and one week immersion in SBF did not result in any substantial progress in bioactivity. After 4 weeks in SBF a new biologically active layer was created on the surface of the biomaterials. In addition, the embryonal mouse fibroblast cell line NIH-3T3 was used for a comparative study of basal cytotoxicity of FHA, HA and FA discs. The sensitivity of these cells for tested biomaterials was evaluated on the basis of two cytotoxic end points: cell proliferation and cell morphology. The basal cytotoxicity of FHA, FA and HA discs was measured by a direct contact method. After 24, 48 and 72 hours, the cell growth was evaluated by direct counting of non-affected cells and cells treated by biomaterials. After 72 hours of biomaterials treatment, about 25% inhibition of cell number and unchanged morphology was found.